Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion-Reference-Cited by-同舟云学术

Secondary Mutations of the EGFR Gene That Confer Resistance to Mobocertinib in EGFR Exon 20 Insertion

Published:2024-01 Issue:1 Volume:19 Page:71-79
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Hamada Akira,Suda Kenichi,Nishino Masaya,Obata Keiko,Oiki Hana,Fukami Tomoyo,Fukuda Shota,Fujino Toshio,Ohara Shuta,Koga Takamasa,Chiba Masato,Shimoji Masaki,Ito Masaoki,Takemoto Toshiki,Soh Junichi,Tsutani Yasuhiro,Mitsudomi Tetsuya

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference31 articles.

1. New and emerging targeted treatments in advanced non-small-cell lung cancer;Hirsch;Lancet,2016

2. EGFR exon 20 insertion mutations in lung adenocarcinomas: prevalence, molecular heterogeneity, and clinicopathologic characteristics;Arcila;Mol Cancer Ther,2013

3. Diverse EGFR exon 20 insertions and co-occurring molecular alterations identified by comprehensive genomic profiling of NSCLC;Riess;J Thorac Oncol,2018

4. Structure-based classification predicts drug response in EGFR-mutant NSCLC;Robichaux;Nature,2021

5. Comparative clinical outcomes for patients with advanced NSCLC harboring EGFR exon 20 insertion mutations and common EGFR mutations;Bazhenova;Lung Cancer,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for enhancing non-small cell lung cancer treatment: Integrating Chinese herbal medicines with epidermal growth factor receptor-tyrosine kinase inhibitors therapy;European Journal of Pharmacology;2024-10

2. Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer;European Journal of Cancer;2024-09

3. The current landscape, advancements, and prospects in the treatment of patients with EGFR exon 20 insertion mutations warrant scientific elucidation;Frontiers in Oncology;2024-06-11

4. Targeted Therapies for EGFR Exon 20 Insertion Mutation in Non-Small-Cell Lung Cancer;International Journal of Molecular Sciences;2024-05-29

5. The Impact of On-Target Resistance Mediated by EGFR-T790M or EGFR-C797S on EGFR Exon 20 Insertion Mutation Active Tyrosine Kinase Inhibitors;JTO Clinical and Research Reports;2024-01